Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

at 1-888-477-2403 (available Monday-Friday 9 a.m. to 8 p.m. Eastern Time) for information on how to return the affected products and receive a full refund. For more detailed information, consumers should visit our website at www.novartisOTC.com as of January 9, 2012. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Adverse events that may be related to the use of these products may be reported to FDA's MedWatch Adverse Event Reporting Program either online, by regular mail or by fax:

  • Online: www.fda.gov/medwatch/report.htm
  • Regular Mail: use postage-paid FDA form 3500 available at:
    www.fda.gov/MedWatch/getforms.htm.
    Mail to MedWatch, FDA, 5600 Fishers Lane, Rockville, MD  20852-9787
  • Fax: 1-800-FDA-0178
  • These actions announced today, highlight the strong Novartis commitment to a single quality standard for the Novartis Group. The Novartis Group is making the necessary investments and committing the right resources to ensure these are implemented across the entire Novartis Group network. The high quality of Novartis products and operations has been critical to building the Novartis Group reputation over the past 15 years. Novartis Group is committed to ensuring the highest standard for patients who rely on our products and medicines.

    Novartis Consumer Health Inc. plans to gradually resume operations at its Lincoln, NE site following implementation of planned improvements and in agreement with the FDA. The Novartis Consumer Health Inc. Lincoln, NE facility produces a variety of products mainly for the US market with annual sales value of less than 2% of Novartis Group sales. At this stage, it is not possible to determine when the plant will resume
    '/>"/>

    SOURCE Novartis Consumer Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
    2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
    3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
    4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
    5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
    6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
    7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
    8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
    9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
    10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
    11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... Weiss LLP is reporting that on July 13, 2015, the ... Bard, the manufacturer of Inferior vena cava (IVC) filters ... agency found at two of Bard,s facilities. Bard was previously ... during Inspectional Observations that occurred on November 18, 2014, through ... , location and on October 6, 2014, through November 25, ...
    (Date:7/31/2015)... July 31, 2015  Boston Children,s Hospital physicians ... 3D printing of their anatomy before undergoing high-risk ... malformations (abnormalities in the brain,s blood vessels) that ... today in the Journal of Neurosurgery: Pediatrics ... printing and synthetic resins to create custom, high-fidelity ...
    (Date:7/31/2015)... Inc. (Nasdaq: SMLR ), a company that provides ... groups, today reported financial results for the second quarter ... second quarter of 2015, Semler reported continued progress with ... quarter revenue growth of 8%, and quarter over quarter ... 18%," said Doug Murphy-Chutorian, M.D., chief executive officer of ...
    Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
    ... Sectra to Demonstrate its Multi-Modality Breast Imaging PACS at the   ... ) in Orlando, FL from October 23-26 ...   (NASDAQ OMX Stockholm: SECT B)   announces an agreement ... its multi-modality Breast Imaging PACS. "We selected Sectra ...
    ... 20, 2011 WaferGen Biosystems, Inc. (OTCBB:WGBS), an ... to strengthen domain leadership and enhance commercialization expertise ... System.   As an initial step, ... and a director of Helicos BioSciences Corporation, as ...
    Cached Medicine Technology:Sectra to Provide Breast Imaging PACS to Allison Breast Center at Monument Radiology 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 2WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System 3
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source of ... the MGM Grand Garden Arena. Fans of every genre of music will have an ... 18th, the first day of the festival, the following artists will perform: Sam Smith, ...
    (Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, Sigma ... the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. Key ... meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit of ...
    (Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Ticket Down ... is currently going on in Chicago at Grant Park. The festival will end ... of North America to Chicago for the annual Lollapalooza. This unique and unbelievably ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by ... predictive health analytics , Jvion continues to disrupt the predictive analytic and ... that targets patient and population level illness to drive prevention and better health ...
    (Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to ... Downtown Memphis on October 3, 2015. The Ride to Fight On is a cycling ... between Methodist Healthcare, The West Clinic and The University of Tennessee Health Science Center. ...
    Breaking Medicine News(10 mins):Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
    ... ATS 2011, DENVER A Wednesday morning session ... of military deployment to Iraq and Afghanistan. Presenters ... epidemiologic studies, animal toxicology studies, and clinical lung ... are returning from Southwest Asia. D6 "Occupational ...
    ... By Steven Reinberg HealthDay Reporter , TUESDAY, ... medications such as Nexium, Prevacid or Prilosec can successfully ... research. Millions of Americans experience what,s known formally ... is caused by acidic stomach contents washing up into ...
    ... 2011, DENVER Surrogate decision-makers faced with the difficult ... help thanks to a new decision aid aimed at ... conducted by researchers in North Carolina, Pennsylvania and Washington ... aid significantly improved the often daunting decision-making process. ...
    ... to surgeons, anyone who has pulled an all-nighter knows there ... focusing, a fuzzy memory and other cognitive impairments. Now, ... and the neurochemical basis for sleep deprivation,s effects on memory. ... School of Arts and Sciences and director of the University,s ...
    ... HealthDay Reporter , TUESDAY, May 17 (HealthDay News) ... plan to meet Tuesday and Wednesday to decide whether ... of medicines containing acetaminophen need to be fine-tuned to ... liver failure and even death. Currently, the labels ...
    ... By Amanda Gardner HealthDay Reporter , TUESDAY, May ... percent of their hospital emergency rooms in the past 20 ... 35 percent, new research shows. And the closures disproportionately ... are poor, publicly insured or uninsured -- people without access ...
    Cached Medicine News:Health News:Occupational lung diseases in Iraq and Afghanistan veterans 2Health News:Pills, Surgery Both Effective for Chronic Reflux: Study 2Health News:Pills, Surgery Both Effective for Chronic Reflux: Study 3Health News:Decision aid helps families, clinicians communicate about care decisions 2Health News:Decision aid helps families, clinicians communicate about care decisions 3Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 2Health News:Penn researchers identify the roots of memory impairment resulting from sleep deprivation 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 2Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 3Health News:FDA Panels to Weigh Dosing Labels for Kids' OTC Fever Relievers 4Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 2Health News:Almost 30% of Urban ERs Closed During Past Two Decades: Study 3
    ... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
    ... cytometer especially suited for cell analysis ... CyFlow allows to analyze scatter signals ... fluorescence channels. Data acquisition, analysis, and ... built-in PC employing Partec DPAC software, ...
    This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
    The Cytomics FC 500 Series delivers flexible testing, powerful software and a user-friendly interface features that help researchers optimize their overall workflow efficiency while maintaining true ...
    Medicine Products: